© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Fenofibrate showed up in medicine after researchers started taking a closer look at lipid-lowering agents back in the 1970s. At that time, doctors wanted something better to help folks managing high cholesterol and triglyceride issues. Clofibrate marked the starting point, but it brought along some safety concerns. French scientists then designed fenofibrate, refining the chemical structure to boost its potency and safety. Regulators in Europe began approving it in the early 1980s. By the late 1990s and early 2000s, the FDA gave the go-ahead, expanding fenofibrate’s reach into North American clinics and launching studies on its broader benefits for cardiovascular risk, particularly in people with diabetes and metabolic syndrome.
Doctors mostly prescribe fenofibrate to help lower cholesterol, particularly the bad kind (LDL), along with triglycerides. It’s found in pharmacies as tablets and capsules in several strengths. Most patients take it once a day with food, as this bumps up its absorption in the digestive system. Brand names like Tricor, Antara, Lipofen, and Lofibra show up on labels, but generic forms dominate the market because insurance providers and health systems want to keep things affordable. These generics go through rigorous checks to prove they perform as well as brand-name options, so people can trust their safety and effectiveness.
Fenofibrate doesn’t mix well with water, making it a challenge for scientists and pharmacists working on absorption. Its white, crystalline powder form turns greasy under the slightest touch. The chemical formula is C20H21ClO4, and it packs a molecular weight of 360.83 g/mol. Its melting point sits around 80 to 82°C. Its solubility in lipids explains why taking it with food—especially some healthy fats—makes it more effective. These physical traits matter because pharmacists want to give patients a product that works well inside the body, without causing unnecessary side effects.
Regulatory agencies have strict measurements for fenofibrate. Tablets contain a precise dose, commonly 48 mg or 145 mg per unit, confirmed through high-performance liquid chromatography. Manufacturers print clear info on each carton and bottle. Labels include dosing instructions, active ingredient amount, lot number, expiration date, side effect warnings, and storage conditions. Medications stay stable when sealed and stored under 30°C, away from light and moisture. Each shipment includes a certificate of analysis, safety data sheet, and regulatory documents, showing total commitment to transparency and compliance.
Synthesis begins with 4-chlorobenzoyl chloride and isobutyric anhydride in a controlled environment. This reaction produces an acid chloride intermediate. Chemists then combine this with p-chlorobenzoic acid and 2-methylpropanoic acid to create the final fenofibrate compound. The compound then goes through a crystallization step, where cool solvents separate it out for drying and purification. In industry, large stainless steel reactors manage temperature and pressure to maintain quality at scale, while technicians use high-purity solvents to prevent contamination. Every batch receives a full set of purity tests and impurity screening before moving to tableting or encapsulation.
Fenofibrate belongs to the fibric acid derivatives and acts as a prodrug—meaning it relies on the liver to activate it. After swallowing, the body's enzymes snip off the isopropyl ester group, turning it into fenofibric acid, the active form. Researchers have modified the molecule to improve absorption and stability. Some companies experiment with micronization technology, creating tiny particles for faster and more predictable absorption. Pharmaceutical scientists continue to explore additional structural tweaks that might offer smoother action or higher selectivity for certain patient groups, tailoring therapies to a variety of metabolic needs.
In the world of pharmacy, fenofibrate appears with many different labels. Besides the chemical name 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid, doctors and pharmacists recognize it as Fenofibric acid isopropyl ester. Brand names include Tricor, Lipidil, and Lipanthyl, with generics often simply marked as Fenofibrate Tablets or Capsules. Different countries use their own trademarks—this creates discussion among healthcare workers trying to navigate prescriptions and insurance databases. Regardless of naming, the active molecule and its role stay the same.
Every player in fenofibrate’s production and use—from the lab worker to the hospital pharmacist—follows safety guidelines. Handling the compound needs gloves, closed shoes, and an exhaust-ventilated workbench. Regulatory standards prohibit contamination, verifying batch purity and making sure no harmful byproducts tag along for the ride. In prescription settings, doctors watch for interaction risks—especially with blood thinners and statins—to avoid side effects like muscle breakdown. Patient education forms the backbone of safe use. Pharmacists remind people to report unexplained pain, stay hydrated, keep up regular blood work, and store their pills away from young children and pets.
Doctors use fenofibrate for patients with mixed dyslipidemia—where both cholesterol and triglyceride levels run high. It often plays a supporting role alongside statins, especially for those unable to reach cholesterol goals with one medicine alone. Clinical guidelines in the U.S., Europe, and Asia recommend fenofibrate in specific situations: adults with severe hypertriglyceridemia, or diabetes-related lipid problems. Researchers now explore whether this drug can help prevent pancreatitis in adults at risk. Some cardiologists also look beyond cholesterol, studying fenofibrate’s impact on inflammation and blood vessel function.
Laboratories worldwide put fenofibrate under the microscope, searching for stronger evidence of its clinical benefit. Not all trials agree about its ability to lower heart attack risk. The FIELD and ACCORD studies gave mixed results—lower rates of microvascular complications, but not as much improvement in big cardiovascular outcomes. The pharmaceutical industry works on new delivery forms, like slow-release and dual-action pills that pair fenofibrate with other lipid-control agents. Also, attention shifts toward personalized medicine, examining gene variations in patients who see the most benefit, or suffer the most serious side effects.
While generally well-tolerated, fenofibrate occasionally causes muscle pain, liver enzyme changes, or digestive discomfort. Reports of severe muscle problems (rhabdomyolysis) raised flags, especially for patients also taking statins. Animal studies peg the lethal dose far above prescription levels, but long-term use needs careful monitoring. Doctors routinely check kidney and liver function tests. Cases of gallstone formation exist, prompting more careful use among people with gallbladder issues. Toxicology experts test for potential carcinogenicity and genotoxicity, keeping an eye on results for rare but serious problems over decades-long follow-up.
Looking forward, fenofibrate may carve out new spaces in metabolic disease treatment. Scientists investigate whether it helps reduce inflammation or alters the gut microbiome in beneficial ways. Efforts grow toward developing combination pills that address both cholesterol and blood sugar in type 2 diabetes. Some research goes even further—probing fenofibrate’s influence on eye complications in diabetes, especially retinopathy. The shift toward patient-specific solutions could let doctors select people most likely to benefit, moving beyond the one-size-fits-all playbook. This ongoing push keeps fenofibrate at the center of conversations about how to combat global heart disease and diabetes epidemics.
Heart disease runs in my family, so keeping an eye on cholesterol numbers became part of my adult routine. Every year, doctors order the same blood tests and circle the “lipids” section. The doctor wants to see triglycerides low, and HDL—or “good cholesterol”—high. Yet, in clinics across the country, it’s the triglyceride number that wakes up concern, especially as diabetes and obesity rates keep climbing. Fenofibrate, which shows up under brand names like Tricor, targets this specific number. Doctors prescribe it to bring down high triglycerides and boost HDL. From an everyday perspective, the doctor pulls out the prescription pad to help head off bigger problems down the road: heart attack, stroke, or damage to blood vessels.
Decades of research echo the same point: high triglycerides do more than just mess with blood test results. Extra fat circulating in your blood pressures your pancreas, gums up your arteries, and raises chances for heart issues. People with diabetes, thyroid problems, or extra weight hit these roadblocks more often, making drugs like fenofibrate a go-to for doctors. The American Heart Association sets triglyceride levels under 150 mg/dL as the “safe zone.” Go higher, and risks jump. Fenofibrate’s main job centers on breaking down leftover fat in the blood, giving the heart less to fight against every single day.
Most people think statins fix all cholesterol problems, but they don’t always tackle triglycerides head-on. Many of my peers and older relatives saw their LDL numbers drop, but the triglycerides barely budged. That’s where fenofibrate comes in. Doctors mix and match medications to hit all the marks, keeping statins in the routine while adding fenofibrate for stubborn triglyceride cases. Recent guidelines from organizations like the American Diabetes Association recommend fenofibrate alongside statins for people with both diabetes and high triglycerides.
Fenofibrate isn’t a miracle cure. Doctors tell you to cut saturated fat, drop sugar, and walk more—those steps matter as much as any pill. Fenofibrate can stir up side effects, too. Some people face muscle aches, and others notice liver numbers shifting during blood tests. The FDA reminds doctors to watch for interactions, especially since mixing fenofibrate with certain cholesterol drugs can raise the risk of muscle breakdown. Each year, regulators publish safety updates and advise routine monitoring.
Anyone thinking of starting fenofibrate needs a game plan. Doctors ask lots of questions: Is there liver disease? Kidney trouble? Can diet changes help enough on their own? The doctor often turns to this drug after food tweaks and exercise haven’t lowered triglycerides enough. Routine blood work gives a sense of whether the drug does its job or needs a dose change. Experiences differ, and talking openly with a trusted doctor sheds light on risks and benefits for each life stage and medical history.
Health isn’t just about a single test result. Fenofibrate serves as one tool in the toolbox, best paired with lifestyle changes and a close partnership with a medical team. Staying informed, asking questions, and understanding the “why” behind medications like fenofibrate opens the door to healthier days ahead.
Fenofibrate shows up in many medicine cabinets for good reason. Doctors turn to it if blood tests keep flagging high cholesterol or if triglycerides just refuse to budge. This medication helps lower those numbers, and for people struggling to stay in the heart-healthy zone, it can make a real difference. Still, no one takes a pill and expects everything to run perfectly. Like so many prescriptions, fenofibrate brings its own set of problems—even when taken exactly as the doctor recommends.
Digestive issues turn up early when someone starts this drug. Most people I’ve met who’ve taken it talk about an unsettled stomach. Nausea can pop up out of nowhere. Some complain about aches in the belly, diarrhea, or even constipation. Anyone who already struggles with stomach issues knows this makes everyday life tougher. No magic trick wipes out these problems overnight, but taking the medication with food tends to help for some.
Another common story centers around headaches. They aren’t always intense, but they do hang around. People have described headaches that come and go, then ease off after a week or two. Sometimes, tiredness feels heavier. For some, it’s a sluggishness that can’t be shaken, even after a full night’s sleep.
Liver health matters a lot here. Over the years, clinic visits taught me that fenofibrate sometimes pushes liver enzymes higher than normal. Regular blood work is a must. Doctors watch for signals that the medicine is making the liver work too hard. Many folks get a sense of safety knowing they’re being monitored, but the anxiety about tests never totally disappears.
Muscle aches crawl onto the list of complaints, especially for people who already take statins. Anyone who notices their muscles feeling sore or unusually weak needs to call their doctor right away. Rarely, a serious condition called rhabdomyolysis shows up, damaging the muscles and kidneys. This side effect sounds scary, and it is, but it’s also truly uncommon. It’s the slow, mild muscle aches that frustrate most people day to day.
Another piece of the puzzle has to do with blood sugar. Some studies show fenofibrate bumps up fasting blood sugar, creating more work for those managing diabetes. For people who already check their numbers, it means paying even closer attention and making tweaks with their care team. I’ve talked with patients who needed to adjust insulin after starting fenofibrate, and that juggling act definitely adds stress.
Fenofibrate can be a life-changer for folks who can’t bring their cholesterol down with diet and exercise alone. Still, sticking with it sometimes means dealing with headaches or keeping digestion in check. Regular blood tests become part of the routine. Open conversations with doctors help spot trouble early; most people find relief knowing they have guidance and a plan. Increasing hydration, healthy snacks, and timely reporting of unusual pain can head off the worst problems. Medicine never gives free rides, but understanding what to watch for can help people balance the risks and rewards.
Fenofibrate steps in for folks looking to lower their cholesterol and triglyceride levels. Extra cholesterol doesn’t just float around doing nothing — it can raise your risk of heart attacks, strokes, and all sorts of trouble. I’ve seen friends in their 40s caught off guard by high cholesterol, despite eating well and working out. Their doctors didn’t shrug things off just because they were still young; they addressed it head-on. That’s where medication like fenofibrate fits into the bigger health picture.
Doctors prescribe fenofibrate in different forms: standard tablets, capsules, or micronized tablets. Taking it once a day suits most folks. Swallow the pill whole with plenty of water. Aim for the same time every day, not just when you remember. If your doctor says to take your dose with food, it isn’t just a suggestion. Taking it with a meal improves how your body absorbs it and can help avoid stomach upset. Skipping meals or taking the drug on an empty stomach can lead to less predictable results.
Missing a dose once isn’t the end of the world, but doubling up to make up for it can throw things off. Just stick to your schedule — if you remember close to the next dose, skip the one you missed. Most importantly, don’t go off the medication on your own, even if you feel fine. Cholesterol levels don’t work like a headache — you can have no symptoms and still be at risk. Doctors check your progress through blood tests and adjust as needed.
Every medication has side effects. Fenofibrate is no exception. Some people notice stomach pain, back aches, or even changes in mood. If you start getting muscle pain or weakness that sticks around, tell your doctor right away. Rare problems with the liver or pancreas can show up and might not always feel obvious. Keeping up with regular blood tests keeps you out of the dark.
Mixing fenofibrate with other medications, like blood thinners (warfarin), can lead to complications. That’s not just a problem for people who take lots of prescriptions — even over-the-counter drugs or herbal supplements can interact. Your pharmacist plays a big part here, so always keep them in the loop. Health isn’t only about what you take; it’s how everything works together.
Popping a pill isn’t a free pass to ignore the rest of your life. Fenofibrate works better when you commit to a healthy diet, get regular movement in your day, and quit smoking. Results don’t show up overnight. Monitoring progress comes from honest conversations with your healthcare provider and sticking with the plan long term.
At the end of the day, taking fenofibrate is about lowering your risk before something bad happens—not fixing a problem after things go wrong. If you have questions about your medication, no question is too small. The best defense against heart disease or high cholesterol is information and consistency, not just the pills in your weekly pillbox.
Medication can feel like a puzzle if you don’t ask for help. Doctors, pharmacists, and dietitians all want you to get results and avoid side effects. Keeping communication open will keep surprises to a minimum and set you up for better health in the long run.
Taking more than one pill isn’t rare for folks who are juggling high cholesterol, blood pressure, or diabetes. Fenofibrate comes up a lot for people aiming to get their triglycerides or cholesterol under control. Some will wonder how safe it feels to combine this medicine with the bottles that already line their cabinets. I’ve watched family and friends deal with “polypharmacy.” The pharmacist looks through the list, makes notes, sometimes flinches at potential risks. These concerns aren’t just paperwork; they play out in doctor’s offices, kitchens, and work lunchrooms everywhere.
Fenofibrate works well at lowering triglycerides and sometimes, small LDL cholesterol particles. Problems pop up when it lands next to certain other drugs. Statins often sit high on the list. Together, these don’t always play nicely. The combo can raise the chance of muscle pain, tenderness, weakness, and even muscle breakdown—rhabdomyolysis. That’s scary enough to have people call in worried about muscle cramps after a long walk. Data from the FDA and Mayo Clinic backs this up. Anyone curious should check those sources, because they’ll see muscle problems flagged clearly.
Besides statins, blood thinners like warfarin make doctors double-check. Fenofibrate could boost the effect of warfarin, making bleeding more likely. I’ve seen folks give up leafy greens, tip-toe around bruises, and fret over cuts that won’t stop bleeding. This combination deserves real respect. Regular blood tests, such as INR for warfarin users, can help prevent dangerous surprises. A trusted doctor who checks levels saves all sorts of trouble. People on repaglinide—used for diabetes—face a higher chance of low blood sugar if they add fenofibrate. Anyone feeling clammy, shaky, or faint with this mix should tell their healthcare team fast.
As more people live longer and deal with several conditions at once, drug combinations become normal. Polypharmacy has doubled in just a decade, and the problem won’t shrink. Drug interactions land thousands in the ER every year. Fenofibrate is far from the only culprit, but its risks show up often enough for doctors and pharmacists to take these combinations seriously.
Knowledge gives people a lot of power. Keeping a simple, handwritten list of medications helps at every visit. I’ve seen patients save their own skin by showing a nurse every bottle—prescription, over-the-counter, supplement. Digital health apps can help track, but an old-fashioned paper list never runs out of batteries. Bringing someone along to appointments, even by phone, lets important questions get asked. Pharmacies with good records spot problems before they start. If insurance allows, picking one pharmacy for new and refill scripts makes life easier. Pharmacists often catch dangerous mixes before doctors even see the list. Don’t wait for side effects—ask questions, notice body changes, and speak up early.
The real-world solution isn’t just more caution; it’s regular, honest conversation with medical teams. Sticking with that simple habit can keep people healthier, safer, and out of trouble—even as more medications get added over time.
People who struggle with high cholesterol or high triglycerides often talk to their doctor about pills that can help. Fenofibrate comes up a lot. Doctors often turn to it after lifestyle tweaks and statins just don’t deliver enough. Fenofibrate pushes down the amounts of certain fats that tend to clog blood vessels. Less risk of heart attacks or strokes sounds good. That’s the upside. Not everyone should open that bottle, though.
If you have chronic liver problems, stay far away from fenofibrate. The liver processes this drug, and if there’s already a struggle to filter out toxins, adding more work can push things over the edge. It’s not just chronic hepatitis or cirrhosis. I've seen folks with consistently high liver blood tests get told to turn around at the pharmacy counter. Elevated enzymes usually mean the liver already waves a red flag. Ignore it, and the damage gets worse. In severe cases, you could even see liver failure.
If kidneys don’t deliver strong numbers during a check-up, this medicine isn’t right. Fenofibrate gets cleared by the kidneys, and if your filtration isn’t up to scratch, it can build up and poison the body. In the hospital, I once saw an older patient land in trouble after starting fenofibrate without a kidney test. Blood work later showed the numbers way off. Doctors had to stop the drug quickly, but the impact lingered longer than anyone liked. Folks on dialysis or who have poor kidney function from diabetes run bigger risks.
Anyone with a history of gallstones or gallbladder inflammation needs to look for another option. Fenofibrate can mess with bile composition, leading to stone formation and new pain. Once, my neighbor landed back in the ER with sharp pain soon after she’d shrugged off the warning about her “minor” gallbladder history. The doctor later told her those stones flared up again, partly stirred up by the medication.
Every so often, a person finds out the hard way that fenofibrate causes itching, swelling, or rashes. Some allergies don’t show until the pill goes down. In clinics, I’ve watched providers talk with folks who broke out with hives or swelling. They’d never had an allergy to medication before. The best rule here? If you get symptoms after the first dose, don’t try another—it can get worse, even dangerous, quickly.
A lot of people on fenofibrate already take other medicines. Combining fenofibrate with statins can raise muscle damage risk. There’s something called rhabdomyolysis—it’s a rare but real danger that I’ve seen come up, mostly in older adults. Also, blood thinners like warfarin can act up if combined. The blood gets thinner than expected, risking bleeding. Doctors check all the pills before starting fenofibrate, but home medicine cabinets often tell another story.
Doctors help find other answers for pregnant women, nursing moms, and kids. These groups haven’t been studied deeply with fenofibrate. Risks aren’t fully mapped, so most stick to proven options.
Before starting a new pill, regular blood work can spot hidden risks. Bringing up family history, double-checking current medications, and updating the healthcare team after side effects all help. Fenofibrate can offer help to plenty, but for the groups above, it’s best left on the pharmacy shelf.
| Names | |
| Preferred IUPAC name | Isopropyl 2-{4-[(4-chlorobenzoyl)phenoxy]-2-methylpropanoate} |
| Other names |
Fenofibric acid Tricor Antara Lipidil Lipanthyl Fenoglide Lipofen Triglide |
| Pronunciation | /fəˈnəʊ.fɪ.breɪt/ |
| Identifiers | |
| CAS Number | 49562-28-9 |
| 3D model (JSmol) | `3D model (JSmol)` string for **Fenofibrate**: ``` C[C@H](C(=O)O)OC1=CC=C(C=C1)C2=CC=CC=C2C(C)C ``` This is the **SMILES** string representation, which is commonly used for 3D molecular visualization in tools like JSmol. |
| Beilstein Reference | 1284654 |
| ChEBI | CHEBI:5003 |
| ChEMBL | CHEMBL714 |
| ChemSpider | 9699 |
| DrugBank | DB01039 |
| ECHA InfoCard | 100.053.301 |
| EC Number | EC 4.2.1.17 |
| Gmelin Reference | 197670 |
| KEGG | D07931 |
| MeSH | D003998 |
| PubChem CID | 3339 |
| RTECS number | RGU274980 |
| UNII | K40W7JZ5FS |
| UN number | Not regulated |
| Properties | |
| Chemical formula | C20H21ClO4 |
| Molar mass | 360.830 g/mol |
| Appearance | White, crystalline powder |
| Odor | Odorless |
| Density | D 1.2 g/cm³ |
| Solubility in water | insoluble |
| log P | 5.24 |
| Vapor pressure | 6.07E-09 mmHg |
| Acidity (pKa) | pKa = 8.2 |
| Basicity (pKb) | pKb: 15.31 |
| Magnetic susceptibility (χ) | -77.7e-6 cm³/mol |
| Refractive index (nD) | 1.530 |
| Dipole moment | 3.9731 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 427.5 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -789.5 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -8446 kJ/mol |
| Pharmacology | |
| ATC code | C10AB05 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. May cause damage to organs through prolonged or repeated exposure. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | liver, triangle, water, tablet, grapefruit, pregnant |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. Use only as directed by your doctor. Store at room temperature away from moisture and heat. |
| Flash point | 104°C |
| Lethal dose or concentration | LD50 (oral, rat): > 2,000 mg/kg |
| LD50 (median dose) | > 4,500 mg/kg (rat, oral) |
| NIOSH | MN9275000 |
| PEL (Permissible) | Not Established |
| REL (Recommended) | 160 mg daily |
| IDLH (Immediate danger) | No IDLH established. |
| Related compounds | |
| Related compounds |
Benzbromarone Bezafibrate Ciprofibrate Clofibrate Etofibrate Gemfibrozil |
